These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1995882)

  • 1. A new class of calcium antagonists. Synthesis and biological activity of 11-[(omega-aminoalkanoyl)amino]-6,6a,7,8,9,10,10a,11-octahydrodibenzo [b,e]thiepin derivatives.
    Kurokawa M; Sato F; Hatano N; Honda Y; Uno H
    J Med Chem; 1991 Feb; 34(2):593-9. PubMed ID: 1995882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of calcium antagonists. 2. Synthesis and biological activity of 11-[[4-[4-(4-fluorophenyl)-1-piperazinyl]butyryl]amino]-6,11- dihydrodibenzo[b,e]-thiepin maleate and related compounds.
    Kurokawa M; Sato F; Fujiwara I; Hatano N; Honda Y; Yoshida T; Naruto S; Mastumoto J; Uno H
    J Med Chem; 1991 Mar; 34(3):927-34. PubMed ID: 2002473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
    Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats.
    Yamamoto T; Nakatsuji K; Hosoki K; Karasawa T
    Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):673-8. PubMed ID: 8306512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiinflammatory activity of 6,11-dihydro-11-oxodibenzo[b,e]thiepinalkanoic acids and related compounds.
    Ackrell J; Antonio Y; Franco F; Landeros R; Leon A; Muchowski JM; Maddox ML; Nelson PH; Rooks WH; Roszkowski AP; Wallach MB
    J Med Chem; 1978 Oct; 21(10):1035-44. PubMed ID: 309946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
    Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
    Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
    Yamamoto T; Hosoki K; Kikuta C; Karasawa T
    Arzneimittelforschung; 1994 Jun; 44(6):712-4. PubMed ID: 8053969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiinflammatory activity of cis- and trans-6,6a,7,8,9,10,10a,11-octahydro-11-oxodibenzo[b,e]thiepinacetic and -oxepinacetic acids.
    Kurokawa M; Uno H; Nakamura H; Sato F; Naruto S
    J Med Chem; 1990 Feb; 33(2):504-9. PubMed ID: 2299620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and calcium antagonistic activity of a new class of 1,4-dihydropyridines having an alkoxyimino group in position 3.
    Favara D; Nicola M; Pappalardo M; Bonardi G; Luca C; Marchini F; Sardi B
    Farmaco Sci; 1987 Oct; 42(10):697-708. PubMed ID: 3436440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities.
    Inoue H; Konda M; Hashiyama T; Otsuka H; Takahashi K; Gaino M; Date T; Aoe K; Takeda M; Murata S
    J Med Chem; 1991 Feb; 34(2):675-87. PubMed ID: 1995892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel calcium antagonists. Synthesis and structure-activity relationship studies of benzothiazoline derivatives.
    Yamamoto K; Fujita M; Tabashi K; Kawashima Y; Kato E; Oya M; Iso T; Iwao J
    J Med Chem; 1988 May; 31(5):919-30. PubMed ID: 3361580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoalkynyldithianes. A new class of calcium channel blockers.
    Adams TC; Dupont AC; Carter JP; Kachur JF; Guzewska ME; Rzeszotarski WJ; Farmer SG; Noronha-Blob L; Kaiser C
    J Med Chem; 1991 May; 34(5):1585-93. PubMed ID: 2033584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
    J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dibenzothiazepinones as potential calcium channel antagonists. I.
    Li R; Farmer PS; Quillam MA; Howlett SE
    Drug Des Discov; 1993; 10(4):331-42. PubMed ID: 8148472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stereospecifity of the neuroleptic activity and chirality of (+)-3-(2-(4-(8-fluoro-2-methyl-10, 11-dihydrodibenzo(b, f)thiepin-10-yl)-1-piperazinyl)ethyl)-2-oxazolidinone (author's transl)].
    Aschwanden W; Kyburz E; Schönholzer P
    Helv Chim Acta; 1976; 59(4):1245-52. PubMed ID: 950311
    [No Abstract]   [Full Text] [Related]  

  • 19. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.
    Atwal KS; Swanson BN; Unger SE; Floyd DM; Moreland S; Hedberg A; O'Reilly BC
    J Med Chem; 1991 Feb; 34(2):806-11. PubMed ID: 1995904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic and psychotropic agents. XXI. 4-(4-methylpiperazino)-4,5-dihydrobenzo (b) thieno (3,2-f)-thiepin and related compounds.
    Rajsner M; Metysovà J; Protiva M
    Farmaco Sci; 1968 Feb; 23(2):140-8. PubMed ID: 5728669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.